secwatch.observer — SEC 8-K summary
======================================

Issuer:     Design Therapeutics, Inc. (DSGN)
CIK:        0001807120
Form:       8-K
Filed at:   2025-01-13T23:59:59+00:00
Accession:  0000950170-25-004612
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Design Therapeutics updates corporate presentation with no material new information
--------------------------------------------------------------------------------

- Updated corporate presentation filed as Exhibit 99.1 for use in investor meetings.
- No financial results, clinical data, or guidance changes disclosed in the filing.
- Filing includes only the presentation; no other material events reported.
- This is a routine Regulation FD disclosure without specific new facts.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1807120/000095017025004612/0000950170-25-004612-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1807120/000095017025004612/dsgn-20250113.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-004612

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer